These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29606337)

  • 1. New insights into the structure of the MHC class I peptide-loading complex and mechanisms of TAP inhibition by viral immune evasion proteins.
    Praest P; Liaci AM; Förster F; Wiertz EJHJ
    Mol Immunol; 2019 Sep; 113():103-114. PubMed ID: 29606337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen translocation machineries in adaptive immunity and viral immune evasion.
    Mayerhofer PU; Tampé R
    J Mol Biol; 2015 Mar; 427(5):1102-18. PubMed ID: 25224907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular architecture of the MHC I peptide-loading complex: one tapasin molecule is essential and sufficient for antigen processing.
    Hulpke S; Baldauf C; Tampé R
    FASEB J; 2012 Dec; 26(12):5071-80. PubMed ID: 22923333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC I chaperone complexes shaping immunity.
    Thomas C; Tampé R
    Curr Opin Immunol; 2019 Jun; 58():9-15. PubMed ID: 30771631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral immune evasion: Lessons in MHC class I antigen presentation.
    van de Weijer ML; Luteijn RD; Wiertz EJ
    Semin Immunol; 2015 Mar; 27(2):125-37. PubMed ID: 25887630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light control of the peptide-loading complex synchronizes antigen translocation and MHC I trafficking.
    Brunnberg J; Herbring V; Günther Castillo E; Krüger H; Wieneke R; Tampé R
    Commun Biol; 2021 Mar; 4(1):430. PubMed ID: 33785857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of viral immune evasion proteins to inhibit MHC class I antigen processing and presentation.
    Zhou F
    Int Rev Immunol; 2009; 28(5):376-93. PubMed ID: 19811316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of viral immune escape strategies targeting the MHC class I assembly pathway.
    Früh K; Gruhler A; Krishna RM; Schoenhals GJ
    Immunol Rev; 1999 Apr; 168():157-66. PubMed ID: 10399072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transporter associated with antigen processing: a key player in adaptive immunity.
    Eggensperger S; Tampé R
    Biol Chem; 2015 Sep; 396(9-10):1059-72. PubMed ID: 25781678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of autophagy in MHC class I antigen presentation.
    Øynebråten I
    Scand J Immunol; 2020 Nov; 92(5):e12978. PubMed ID: 32969499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Flow Cytometry-Based Approach to Unravel Viral Interference with the MHC Class I Antigen Processing and Presentation Pathway.
    Praest P; de Buhr H; Wiertz EJHJ
    Methods Mol Biol; 2019; 1988():187-198. PubMed ID: 31147941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses.
    Verweij MC; Ressing ME; Knetsch W; Quinten E; Halenius A; van Bel N; Hengel H; Drijfhout JW; van Hall T; Wiertz EJ
    Mol Immunol; 2011 Mar; 48(6-7):835-45. PubMed ID: 21292324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral immune evasion molecules attack the ER peptide-loading complex and exploit ER-associated degradation pathways.
    Lybarger L; Wang X; Harris M; Hansen TH
    Curr Opin Immunol; 2005 Feb; 17(1):71-8. PubMed ID: 15653314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other.
    Said A; Azab W; Damiani A; Osterrieder N
    J Virol; 2012 Aug; 86(15):8059-71. PubMed ID: 22623773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of MHC class I-restricted antigen processing and cross-presentation.
    Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA
    Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of TAP1 and TAP2 gene polymorphisms on TAP function and its inhibition by viral immune evasion proteins.
    Praest P; Luteijn RD; Brak-Boer IGJ; Lanfermeijer J; Hoelen H; Ijgosse L; Costa AI; Gorham RD; Lebbink RJ; Wiertz EJHJ
    Mol Immunol; 2018 Sep; 101():55-64. PubMed ID: 29879547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cowpox virus protein CPXV012 eludes CTLs by blocking ATP binding to TAP.
    Luteijn RD; Hoelen H; Kruse E; van Leeuwen WF; Grootens J; Horst D; Koorengevel M; Drijfhout JW; Kremmer E; Früh K; Neefjes JJ; Killian A; Lebbink RJ; Ressing ME; Wiertz EJ
    J Immunol; 2014 Aug; 193(4):1578-89. PubMed ID: 25024387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC I assembly and peptide editing - chaperones, clients, and molecular plasticity in immunity.
    Thomas C; Tampé R
    Curr Opin Immunol; 2021 Jun; 70():48-56. PubMed ID: 33689959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tapasin: an ER chaperone that controls MHC class I assembly with peptide.
    Grandea AG; Van Kaer L
    Trends Immunol; 2001 Apr; 22(4):194-9. PubMed ID: 11274924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral immune evasins impact antigen presentation by allele-specific trapping of MHC I at the peptide-loading complex.
    Sethumadhavan S; Barth M; Spaapen RM; Schmidt C; Trowitzsch S; Tampé R
    Sci Rep; 2022 Jan; 12(1):1516. PubMed ID: 35087068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.